The Manufacturers Life Insurance Company Makes New $25.72 Million Investment in Ventas, Inc. $VTR

The Manufacturers Life Insurance Company purchased a new stake in shares of Ventas, Inc. (NYSE:VTR) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 289,666 shares of the real estate investment trust’s stock, valued at approximately $25,722,000. The Manufacturers Life Insurance Company owned about 0.06% of Ventas at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. NewEdge Advisors LLC lifted its holdings in shares of Ventas by 856.1% in the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock worth $545,000 after acquiring an additional 7,097 shares during the last quarter. Empowered Funds LLC raised its position in Ventas by 6.8% in the first quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock valued at $576,000 after purchasing an additional 536 shares during the period. Woodline Partners LP raised its position in Ventas by 46.8% in the first quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock valued at $2,532,000 after purchasing an additional 11,739 shares during the period. Focus Partners Wealth lifted its stake in Ventas by 130.4% during the first quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock worth $1,486,000 after purchasing an additional 12,233 shares in the last quarter. Finally, Gamco Investors INC. ET AL acquired a new position in Ventas during the second quarter worth $805,000. 94.18% of the stock is owned by hedge funds and other institutional investors.

Ventas Stock Down 0.6%

Ventas stock opened at $92.89 on Friday. The firm has a market capitalization of $47.65 billion, a P/E ratio of 172.02, a P/E/G ratio of 2.15 and a beta of 0.69. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86. Ventas, Inc. has a twelve month low of $66.38 and a twelve month high of $101.60. The stock’s fifty day simple moving average is $92.22 and its 200-day simple moving average is $87.54.

Ventas (NYSE:VTR) last released its earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.96 by $0.01. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The firm had revenue of $1.73 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period last year, the business posted $0.87 earnings per share. Ventas’s revenue was up 21.7% compared to the same quarter last year. As a group, equities analysts expect that Ventas, Inc. will post 3.89 earnings per share for the current fiscal year.

Insider Transactions at Ventas

In related news, Director Michael J. Embler acquired 2,500 shares of the firm’s stock in a transaction dated Wednesday, June 3rd. The stock was acquired at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This represents a 14.97% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.53% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several research firms recently issued reports on VTR. Scotiabank cut their price objective on Ventas from $95.00 to $88.00 and set a “sector perform” rating on the stock in a report on Thursday, June 18th. Cantor Fitzgerald raised their target price on Ventas from $97.00 to $102.00 and gave the company an “overweight” rating in a report on Friday, July 31st. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $100.00 target price on shares of Ventas in a research report on Tuesday, June 16th. Wells Fargo & Company boosted their price target on shares of Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a research note on Monday, June 1st. Finally, Citigroup increased their price target on shares of Ventas from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Tuesday, August 4th. Fourteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $98.00.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.